Performance and outcome of SCT after relapse
| Evaluable . | Total (n = 200) . | B-lineage (n = 144) . | T-lineage (n = 56) . |
|---|---|---|---|
| Performance of SCT, n | |||
| Any SCT | 149 (75%) | 103 (72%) | 46 (82%) |
| SCT in CR after 1st salvage | 65 (32%) | 51 (35%) | 14 (25%) |
| SCT in later CR | 21 (10%) | 7 (5%) | 14 (25%) |
| SCT without CR | 63 (31%) | 45 (31%) | 18 (32%) |
| No SCT | 51 (25%) | 41 (28%) | 10 (18%) |
| Outcome according to SCT* | |||
| Any SCT | 38% ± 4% | 36% ± 5% | 43% ± 8% |
| SCT in CR after 1st salvage | 56% ± 7% | 50% ± 8% | 77% ± 12% |
| SCT in later CR | 39% ± 11% | 51% ± 20% | 34% ± 13% |
| SCT without CR | 20% ± 5% | 18% ± 6% | 25% ± 11% |
| No SCT | 0%† | 0%† | 0%† |
| Evaluable . | Total (n = 200) . | B-lineage (n = 144) . | T-lineage (n = 56) . |
|---|---|---|---|
| Performance of SCT, n | |||
| Any SCT | 149 (75%) | 103 (72%) | 46 (82%) |
| SCT in CR after 1st salvage | 65 (32%) | 51 (35%) | 14 (25%) |
| SCT in later CR | 21 (10%) | 7 (5%) | 14 (25%) |
| SCT without CR | 63 (31%) | 45 (31%) | 18 (32%) |
| No SCT | 51 (25%) | 41 (28%) | 10 (18%) |
| Outcome according to SCT* | |||
| Any SCT | 38% ± 4% | 36% ± 5% | 43% ± 8% |
| SCT in CR after 1st salvage | 56% ± 7% | 50% ± 8% | 77% ± 12% |
| SCT in later CR | 39% ± 11% | 51% ± 20% | 34% ± 13% |
| SCT without CR | 20% ± 5% | 18% ± 6% | 25% ± 11% |
| No SCT | 0%† | 0%† | 0%† |